SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

Author:  ["Andrea C. Carrano","Esther Eytan","Avram Hershko","Michele Pagano"]

Publication:  Nature Cell Biology

CITE.CC academic search helps you expand the influence of your papers.

Tags:  general   CellBiology   CancerResearch   DevelopmentalBiology   StemCells   Biological

Abstract

Degradation of the mammalian cyclin-dependent kinase (CDK) inhibitor p27 is required for the cellular transition from quiescence to the proliferative state. The ubiquitination and subsequent degradation of p27 depend on its phosphorylation by cyclin–CDK complexes. However, the ubiquitin–protein ligase necessary for p27 ubiquitination has not been identified. Here we show that the F-box protein SKP2 specifically recognizes p27 in a phosphorylation-dependent manner that is characteristic of an F-box-protein–substrate interaction. Furthermore, both in vivo and in vitro, SKP2 is a rate-limiting component of the machinery that ubiquitinates and degrades phosphorylated p27. Thus, p27 degradation is subject to dual control by the accumulation of both SKP2 and cyclins following mitogenic stimulation.

Cite this article

Carrano, A., Eytan, E., Hershko, A. et al. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1, 193–199 (1999). https://doi.org/10.1038/12013

View full text

>> Full Text:   SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

Selective regulation of integrin–cytoskeleton interactions by the tyrosine kinase Src

A new internal-ribosome-entry-site motif potentiates XIAP- mediated cytoprotection